XML 87 R76.htm IDEA: XBRL DOCUMENT v3.21.2
Share-based Payment and Non-Convertible Equity Certificates (Tables)
12 Months Ended
Mar. 31, 2021
Disclosure Of Share-based Payments [Abstract]  
Disclosure of movement in the share-based payment liability The movement in the share-based payment liability during the period is reflected below:
(EUR thousand)
SBPAs of March 31, 2021
Opening balance as of April 17,396 
Valuation up to August 27974 
SBP value as of August 278,370 
Expense recognized in the profit and loss upon capital reorganization58,744 
SBP value as of August 2867,114 
Cash settlements upon reorganization(29,333)
Conversion upon reorganization of remaining SBP liability to equity at FV(37,781)
Closing balance as of March 31, 2021 
Disclosure of movement in the NC-PECs liability
The movement in the NC-PECs liability is reflected below:
(EUR thousand)For the financial year ended March 31
NC-PECs202120202019
Nominal value including accrued interest on NC-PECs issued at the beginning of the year1,920 1,750 1,591 
Mark-to-market fair value charge(138)— — 
Accrued interests on NC-PECs79 (5)159 
Transfer to equity(1,861)— — 
Reclassifications— 175 — 
Total value of NC-PECs direct investment 1,920 1,750 
Value at the beginning of the year2,971 2,744 
Accrued interest120 227 — 
Derecognition of residual amount to profit and loss(101)— — 
Transfer to equity(2,990)— — 
Reclassifications— — 2,744 
Interest bearing obligations towards senior management of Global Blue Group 2,971 2,744 
Total value of NC-PECs including accrued interest 4,891 4,494 
(Thousand of units)For the financial year ended March 31
NC-PECs202120202019
NC-PECs issued at the beginning of the year927 927 927 
Issuance of NC-PECs— — — 
Transfer of NC-PECs to equity(927)— — 
Number of NC-PECs issued 927 927 
Disclosure of share options tranches Four tranches of options vesting on four respective vesting dates have been granted. Within each respective tranche, there are a further four tranches of options with four different exercise prices.
Share options granted (thousands)02/15/202208/15/202208/15/202308/15/2024Total
US$8.50971 324 647 647 2,589 
US$10.50822 274 548 548 2,192 
US$12.50673 224 448 448 1,793 
US$14.50523 175 349 349 1,396 
Total2,989 997 1,992 1,992 7,970 
Disclosure of indirect measurement of fair value of goods or services received, share options granted during period
Grant date11/12/202011/12/202011/12/202011/12/2020
Share price at grant date (USD)10.34 10.34 10.34 10.34 
Expiry date08/15/202608/15/202608/15/202608/15/2026
Exercise price (USD)8.5 10.5 12.5 14.5 
Fair value per share option (USD)0.58 0.20 0.05 0.01 
Disclosure of restricted shares
On November 12, 2020, four tranches, a total of 475,491 restricted shares were granted to employees of the company.
Grant date11/12/202011/12/202011/12/202011/12/2020
Vesting date02/15/202208/15/202208/15/202308/15/2024
Share price at grant date (USD)10.3410.3410.3410.34
Number of shares178,30959,436118,873118,873
Expiry date08/15/202608/15/202608/15/202608/15/2026
Risk free interest rate0.14 %0.16 %0.22 %0.30 %
Fair value per share (USD)8.658.658.658.65